Skip to content

Comparison of injective corneal endothelium transplantation and drag corneal endothelium transplantation

Comparison of injective corneal endothelium transplantation and drag corneal endothelium transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048371
Enrollment
Unknown
Registered
2021-07-06
Start date
2021-08-01
Completion date
Unknown
Last updated
2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corneal endotheliopathy

Interventions

Experimental group:Injective corneal endothelial transplantation
Control group:Drag corneal endothelial transplantation

Sponsors

Eye Hospital, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Because of Fuchs endothelial dystrophy, intraocular lens bullous keratopathy, aphakic bullous keratopathy, endothelial failure after penetrating keratoplasty and other causes of bullous keratopathy, patients need corneal endothelial transplantation; 2.Age >= 18 years old, regardless of gender; 3.All patients had informed consent.

Exclusion criteria

Exclusion criteria: 1.Preoperative intraocular pressure control was poor (IOP > 21mmhg in the latest month); 2.Silicone oil eye; 3.Uveitis occurred repeatedly; 4.Viral keratodermatitis; 5.Iris septal defect of water eye, congenital ocular dysplasia, and all other conditions that seriously affect surgical procedures; 6.Eye infection, intraocular inflammation subsided less than 1 month; 7.Internal eye surgery was performed within 3 months before screening or during the study period; 8.Pregnant and lactating women or women of childbearing age do not take effective contraceptive measures; 9.Preoperative fasting blood glucose > 9.0mmol/l, severe cardiovascular disease history (uncontrollable hypertension, unstable coronary heart disease or myocardial infarction or severe arrhythmia) can not tolerate surgery; 10.The researcher judged that it was not suitable to participate in other situations of the experiment.

Design outcomes

Primary

MeasureTime frame
Corneal endothelial cell density;Corneal endothelial cell loss rate;

Secondary

MeasureTime frame
Visual function;Intraocular pressure;Corneal thickness;Time of operation;Intraoperative and postoperative complications;Graft survival rate;

Countries

China

Contacts

Public ContactChen Wei

The School of Ophthalmology and Optometry, Wenzhou Medical University

chenweimd@hotmail.com+86 86 577 88068879

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026